The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes
Open accessAbstract
The pool of beta cell-specific CD8+ T cells in type 1 diabetes (T1D) sustains an autoreactive potential despite having access to a constant source of antigen. To investigate the long-lived nature of these cells, we established a DNA methylation-based T cell 'multipotency index' and found that beta cell-specific CD8+ T cells retained a stem-like epigenetic multipotency score. Single-cell assay for transposase-accessible chromatin using sequencing confirmed the coexistence of naive and effector-associated epigenetic programs in individual beta cell-specific CD8+ T cells. Assessment of beta cell-specific CD8+ T cell anatomical distribution and the establishment of stem-associated epigenetic programs revealed that self-reactive CD8+ T cells isolated from murine lymphoid tissue retained developmentally plastic phenotypic and epigenetic profiles relative to the same cells isolated from the pancreas. Collectively, these data provide new insight into the longevity of beta cell-specific CD8+ T cell responses and document the use of this methylation-based multipotency index for investigating human and mouse CD8+ T cell differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In support of our findings, a recent study found that circulating β-cell–specific CD8 T cells in T1D patients are epigenetically distinct from TCM, effector memory T (TEM) cells and exhausted CD8 T cells in chronic infection26 (for example, in HIV).”
From An autoimmune stem-like CD8 T cell population drives type 1 diabetes (2022) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,938
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
BSMAP: whole genome bisulfite sequence MAPping program
Xi, Y., & Li, W. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-232 · Cited by 1,216
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902226 · Cited by 1,189
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Alfei, F., Kanev, K., Hofmann, M., Wu, M., Ghoneim, H. E., Roelli, P., Utzschneider, D. T., von Hoesslin, M., Cullen, J. G., Fan, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1326-9 · Cited by 930
Self-citationDe Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Ghoneim, H. E., Fan, Y., Moustaki, A., Abdelsamed, H. A., Dash, P., Dogra, P., Carter, R., Awad, W., Neale, G. A. M., Thomas, P. G., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.007 · Cited by 808
Self-citationAnalysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712
Cited by
Sorted by citations
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
Herold, K. C., Bundy, B. N., Long, S. A., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1902226 · Cited by 1,189
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
Prinzing, B., Zebley, C. C., Petersen, C. T., Fan, Y., Anido, A. A., Yi, Z., Nguyen, P., Houke, H., Bell, M., Haydar, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abh0272 · Cited by 349
Self-citationAn autoimmune stem-like CD8 T cell population drives type 1 diabetes
Gearty, S. V., Dündar, F., Zumbo, P., Espinosa-Carrasco, G., Shakiba, M., Sanchez-Rivera, F. J., Socci, N. D., Trivedi, P., Lowe, S. W., Lauer, P., et al. (2022) · Nature · doi:10.1038/s41586-021-04248-x · Cited by 257
Collier, J. L., Weiss, S. A., Pauken, K. E., Sen, D. R., & Sharpe, A. H. (2021) · Nature Immunology · doi:10.1038/s41590-021-00949-7 · Cited by 237
The immunology of type 1 diabetes
Herold, K. C., Delong, T., Perdigoto, A. L., Biru, N., Brusko, T. M., & Walker, L. S. K. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-023-00985-4 · Cited by 241
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects
Verma, V., Jafarzadeh, N., Boi, S. K., Kundu, S., Jiang, Z., Fan, Y., Lopez, J., Nandre, R. M., Zeng, P., Alolaqi, F., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00818-9 · Cited by 186
Self-citationChromatin accessibility: biological functions, molecular mechanisms and therapeutic application
Chen, Y., Liang, R., Li, Y., Jiang, L., Ma, D., Luo, Q., & Song, G. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02030-9 · Cited by 195
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Li, Z., Tuong, Z. K., Dean, I., Willis, C., Gaspal, F., Fiancette, R., Idris, S., Kennedy, B. C., Ferdinand, J. R., Peñalver, A., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20210749 · Cited by 122
Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3
Grebinoski, S., Zhang, Q., Cillo, A. R., Manne, S., Xiao, H., Brunazzi, E. A., Tabib, T., Cardello, C., Lian, C. G., Murphy, G. F., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01210-5 · Cited by 107
Zebley, C. C., Brown, C., Tian, M., Fan, Y., Alli, S., Boi, S. K., Galletti, G., Lugli, E., Langfitt, D. M., Métais, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110079 · Cited by 109
Self-citationNew developments implicating IL-21 in autoimmune disease
Ren, H. M., Lukacher, A. E., Rahman, Z. S. M., & Olsen, N. J. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102689 · Cited by 100
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Kang, T. G., Lan, X., Tian, M., Chen, H., Alli, S., Lim, S.-E., Bhatara, S., Vasandan, A. B., Ward, G., Bentivegna, S., et al. (2024) · Science · doi:10.1126/science.adl4492 · Cited by 103
Self-citationZheng, W., Wei, J., Zebley, C. C., Jones, L. L., Dhungana, Y., Wang, Y., Mavuluri, J., Long, L., Fan, Y., Youngblood, B., et al. (2021) · Blood · doi:10.1182/blood.2020009309 · Cited by 89
Self-citationTonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
Lamarche, C., Ward‐Hartstonge, K. A., Tian, M., Lin, D. T. S., Huang, Q. B., Brown, A., Edwards, K., Novakovsky, G., Qi, C. N., Kobor, M. S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219086120 · Cited by 87
Self-citationHumblin, É., Korpas, I., Lu, J., Filipescu, D., van der Heide, V., Goldstein, S., Vaidya, A. B., Schanoski, A. S., Casati, B., Selvan, M. E., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg0878 · Cited by 72
Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy
Zebley, C. C., Gottschalk, S. M., & Youngblood, B. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.008 · Cited by 71
Self-citationThe beta cell-immune cell interface in type 1 diabetes (T1D)
James, E. A., Joglekar, A. V., Linnemann, A. K., Russ, H. A., & Kent, S. C. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101809 · Cited by 72
Self-citationMechanisms of T cell exhaustion guiding next-generation immunotherapy
Zebley, C. C., & Youngblood, B. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.04.004 · Cited by 65
Self-citationHu, H., Zakharov, P. N., Peterson, O. J., & Unanue, E. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019743117 · Cited by 63
Cencioni, M. T., Genchi, A., Brittain, G., de Silva, T. I., Sharrack, B., Snowden, J. A., Alexander, T., Greco, R., & Muraro, P. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.813957 · Cited by 61
Lledó-Delgado, A., Preston-Hurlburt, P., Currie, S., Clark, P., Linsley, P. S., Long, S. A., Liu, C., Koroleva, G., Martins, A. J., Tsang, J. S., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci177492 · Cited by 58
A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance
Warshauer, J. T., Belk, J. A., Chan, A. Y. K., Wang, J., Gupta, A. R., Shi, Q., Skartsis, N., Peng, Y., Phipps, J. D., Acenas, D. D., II, et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210759 · Cited by 58
Passeri, L., Andolfi, G., Bassi, V., Russo, F., Giacomini, G., Laudisa, C., Marrocco, I., Cesana, L., Stefano, M. D., Fanti, L., et al. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103051 · Cited by 55
Single-cell sorting based on secreted products for functionally defined cell therapies
Miwa, H., Dimatteo, R., de Rutte, J. M., Ghosh, R., & Carlo, D. D. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00422-x · Cited by 50
Saadey, A. A., Yousif, A., Osborne, N., Shahinfar, R., Chen, Y., Laster, B., Rajeev, M., Bauman, P., Webb, A., & Ghoneim, H. E. (2022) · Nature Immunology · doi:10.1038/s41590-022-01384-y · Cited by 47
Self-citationJiang, W., Xia, T., Liu, C., Li, J., Zhang, W., & Sun, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.705903 · Cited by 48
Srivastava, N., Hu, H., Peterson, O. J., Vomund, A. N., Stremska, M. E., Zaman, M., Giri, S., Li, T., Lichti, C. F., Zakharov, P. N., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.04.017 · Cited by 50
Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
Gonzalez, N. M., Zou, D., Gu, A., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725618 · Cited by 46
IL-12 Signaling Promotes TET2-Mediated DNA Demethylation During CD8 T Cell Effector Differentiation
Zebley, C. C., Abdelsamed, H. A., Ghoneim, H. E., Alli, S., Brown, C., Haydar, D., Tian, M., Harris, T. L., McGargill, M. A., Krenciute, G., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109796 · Cited by 45
Self-citationDNA Methylation and Immune Memory Response
Mittelstaedt, N. N., Becker, A. L., de Freitas, D. N., Zanin, R. F., Stein, R. T., & de Souza, A. P. D. (2021) · Cells · doi:10.3390/cells10112943 · Cited by 45
Mallone, R., Halliez, C., Rui, J., & Herold, K. C. (2022) · Diabetes · doi:10.2337/dbi21-0036 · Cited by 41
Early methionine availability attenuates T cell exhaustion
Sharma, P., Guo, A., Poudel, S., Boada-Romero, E., Verbist, K., Palacios, G., Immadisetty, K., Chen, J., Haydar, D., Mishra, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02223-6 · Cited by 45
Epigenetic regulation of T cell adaptive immunity
Frias, A. B., Boi, S. K., Lan, X., & Youngblood, B. (2021) · Immunological Reviews · doi:10.1111/imr.12943 · Cited by 44
Self-citationEpigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 43
Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
Linsley, P. S., Greenbaum, C. J., & Nepom, G. T. (2021) · Diabetes · doi:10.2337/db20-1185 · Cited by 38
Self-citationThe Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes
Clark, M., Kroger, C. J., Qi, K., & Tisch, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615371 · Cited by 37
Persistence of self-reactive CD8+ T cells in the CNS requires TOX-dependent chromatin remodeling
Pagé, N., Lemeille, S., Vincenti, I., Klimek, B., Mariotte, A., Wagner, I., Liberto, G. D., Kaye, J., & Merkler, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21109-3 · Cited by 36
Collier, J. L., Pauken, K. E., Lee, C. A. A., Patterson, D. G., Markson, S. C., Conway, T. S., Fung, M. E., France, J. A., Mucciarone, K., Lian, C. G., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221920 · Cited by 33
An update on epigenetic regulation in autoimmune diseases
Mei, X., Zhang, B., Zhao, M., & Lu, Q. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100176 · Cited by 33
Riegel, D., Romero-Fernández, E., Simon, M., Adenugba, A., Singer, K., Mayr, R., Weber, F., Kleemann, M., Imbusch, C. D., Kreutz, M. P., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2022.12.029 · Cited by 35
Epigenetic regulation of T cell exhaustion in cancer
Kang, T. G., Johnson, J. T., Zebley, C. C., & Youngblood, B. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00883-y · Cited by 36
Self-citationStem cell-like memory T cells: A perspective from the dark side
Gao, S., Liang, X., Wang, H., Bao, B., Zhang, K., Zhu, Y., & Shao, Q. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104273 · Cited by 31
Conserved epigenetic hallmarks of T cell aging during immunity and malignancy
Tian, M., Soerens, A. G., Alli, S., Kang, T. G., Vasandan, A. B., Wang, Z., Vezys, V., Kimura, S., Iacobucci, I., Baylin, S. B., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00649-5 · Cited by 32
Self-citationAljobaily, N. A., Allard, D., Perkins, B., Raugh, A., Galland, T., Jing, Y., Stephens, W. Z., Bettini, M. L., Hale, J. S., & Bettini, M. (2024) · Immunity · doi:10.1016/j.immuni.2024.09.016 · Cited by 30
Chen, Z., Zhu, Z., Hu, T., Yao, C., & Wu, T. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01378-4 · Cited by 37
Yang, K., Zhang, Y., Ding, J., Li, Z., Zhang, H., & Zou, F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1377322 · Cited by 30
Ou, K., Hamo, D., Schulze, A. S., Roemhild, A., Kaiser, D., Gasparoni, G., Salhab, A., Zarrinrad, G., Amini, L., Schlickeiser, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751590 · Cited by 25
Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
Deligne, C., You, S., & Mallone, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040542 · Cited by 26
Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset
Golden, G. J., Wu, V. H., Hamilton, J. T., Amses, K. R., Shapiro, M. R., Japp, A. S., Liu, C., Pampena, M. B., Kuri-Cervantes, L., Knox, J. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59626-0 · Cited by 27
Mu-Mosley, H., Ostermann, L. B., Müftüoğlu, M., Vaidya, A. B., Bonifant, C. L., Velasquez, M. P., Gottschalk, S. M., & Andreeff, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.880108 · Cited by 20
Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells
Peters, L. D., Yeh, W.-I., Arnoletti, J. M., Brown, M. E., Posgai, A. L., Mathews, C. E., & Brusko, T. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1142648 · Cited by 18
Kong, Y., Jing, Y., Allard, D., Scavuzzo, M. A., Sprouse, M. L., Borowiak, M., Bettini, M. L., & Bettini, M. (2022) · European Journal of Immunology · doi:10.1002/eji.202149690 · Cited by 16
Epitope-based precision immunotherapy of Type 1 diabetes
Firdessa-Fite, R., Genzano, C. B., Mallone, R., & Creusot, R. J. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2154098 · Cited by 15
The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes
WIEDEMAN, A. E., Speake, C., & Long, S. A. (2021) · Immunology and Cell Biology · doi:10.1111/imcb.12437 · Cited by 15
Self-citationHarnessing CD8+ T‐cell exhaustion to treat type 1 diabetes
Kwong, C.-T. J., Selck, C., Tahija, K., McAnaney, L. J., Le, D. V., Kay, T. W. H., Thomas, H. E., & Krishnamurthy, B. (2021) · Immunology and Cell Biology · doi:10.1111/imcb.12444 · Cited by 15
Autoreactive CD8 T cells in NOD mice exhibit phenotypic heterogeneity but restricted TCR gene usage
Kasmani, M. Y., Ciecko, A. E., Brown, A. K., Петрова, Г. В., Gorski, J., Chen, Y., & Cui, W. (2022) · Life Science Alliance · doi:10.26508/lsa.202201503 · Cited by 14
Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective
Samassa, F., & Mallone, R. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000735 · Cited by 15
Sun, F., Yang, C., Wang, F., Rong, S.-J., Luo, J., Lu, W.-Y., Yue, T., Wang, C., & Liu, S. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01110-7 · Cited by 13
Viruses as a potential environmental trigger of type 1 diabetes mellitus (Review)
Abrantes, J., de Azevedo, J. C. V., Fernandes, F., Almeida, V., de Oliveira, L. C., Oliveira, M. F. D., de Araújo, J. M. G., Lanza, D. C. F., Bezerra, F., Andrade, V. S., et al. (2024) · Biomedical Reports · doi:10.3892/br.2024.1770 · Cited by 20
Zhou, H., Zheng, Z., Fan, C., & Zhou, Z. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.01.001 · Cited by 15
Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes?
Snethlage, C. M. F., de Wit, D. F., Wortelboer, K., Rampanelli, E., Hanssen, N. M. J., & Nieuwdorp, M. (2024) · Immunological Reviews · doi:10.1111/imr.13345 · Cited by 13
Grebinoski, S., Pieklo, G. P., Zhang, Q., Visperas, A., Cui, J., Goulet, J., Xiao, H., Brunazzi, E. A., Cardello, C., Herrada, A. A., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300216 · Cited by 13
Räuber, S. J., Schulte‐Mecklenbeck, A., Willison, A., Hagler, R., Jonas, M., Pul, D., Masanneck, L., Schroeter, C. B., Golombeck, K. S., Lichtenberg, S., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03269-3 · Cited by 14
Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity
Fonta, N., Pagé, N., Klimek, B., Piccinno, M., Liberto, G. D., Lemeille, S., Kreutzfeldt, M., Kastner, A. L., Ertuna, Y. I., Vincenti, I., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241188 · Cited by 13
Stem-like T cells and niches: Implications in human health and disease
Yi, L., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907172 · Cited by 15
Activated-memory T cells influence naïve T cell fate: a noncytotoxic function of human CD8 T cells
Sasaki, K., Moussawy, M. A., Abou‐Daya, K. I., Macedo, C., Hosni-Ahmed, A., Liu, S., Juya, M., Zahorchak, A. F., Metes, D., Thomson, A. W., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03596-2 · Cited by 11
Self-citationMass cytometry and type 1 diabetes research in the age of single-cell data science
Rahman, A. H., & Homann, D. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000549 · Cited by 11
Defining the Molecular Hallmarks of T-Cell MemoryPreprint
Zebley, C. C., Akondy, R. S., Youngblood, B., & Kissick, H. T. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a037804 · Cited by 10
Self-citationYue, M., He, X., Min, X., Yang, H., Xu, H., Wu, W., Zhong, J., Mei, A., & Chen, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462384 · Cited by 11
Selck, C., Jhala, G., George, D. J. D., Kwong, C.-T. J., Christensen, M. K., Pappas, E. G., Liu, X., Ge, T., Trivedi, P., Kallies, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315419121 · Cited by 10
Clinical and experimental treatment of type 1 diabetes
Long, S. A., & Buckner, J. H. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac077 · Cited by 9
Obesity and Autoimmunity Epidemic: The Role of Immunometabolism
Colamatteo, A., Fusco, C., Matarese, A., & Matarese, G. (2025) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-111324-122456 · Cited by 10
Niederlová, V., Neuwirth, A., Neuman, V., Michalik, J., Charvatova, B., Modrák, M., Šumnı́k, Z., & Štěpánek, O. (2025) · Nature Communications · doi:10.1038/s41467-025-66459-4 · Cited by 9
Ettinger, R. A., Buitinga, M., Vandamme, C., Afonso, G., Gómez, R., Arribas-Layton, D., Bissenova, S., Speake, C., Reijonen, H., Kinnunen, T. T., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad434 · Cited by 8
Self-citationApplications of single‐cell omics for chimeric antigen receptor T cell therapy
Ghaffari, S., Saleh, M., Akbari, B., Ramezani, F. M., & Mirzaei, H. R. (2023) · Immunology · doi:10.1111/imm.13720 · Cited by 8
Latent EBV enhances the efficacy of anti-CD3 mAb in Type 1 diabetes
Lledó-Delgado, A., Preston‐Hurlburt, P., Higdon, L. E., Hu, A. K., James, E. A., Lim, N., Long, S. A., McNamara, J., Nguyen, H. D., Serti, E., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60276-5 · Cited by 10
Self-citationEstablishment of CD8+ T Cell Thymic Central Tolerance to Tissue-Restricted Antigen Requires PD-1
May, J. F., Kelly, R. G., Suen, A. Y. W., Kim, J. I., Kim, J., Anderson, C. C., Rayat, G. R., & Baldwin, T. A. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200775 · Cited by 6
Assessing effector T cells in type 1 diabetes
Arif, S., Pujol‐Autonell, I., & Eichmann, M. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000553 · Cited by 6
Zhao, R., Su, Z., Gu, J., Zhao, H., Bian, L., Yin, J., Cai, Y., Yang, T., Gu, Y., & Xu, X. (2025) · BMC Medicine · doi:10.1186/s12916-025-04001-5 · Cited by 6
CAR T cells need a pitstop to win the race
Zebley, C. C., & Youngblood, B. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.011 · Cited by 5
Self-citationThe role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications
Fazeli, P., Abolhasani, S., Karamali, N., Hajivalili, M., Daryabor, G., Panji, M., Karimian, M., & Hosseini, M. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103759 · Cited by 4
Innate-like memory T cells rapidly emerge in humans after gene therapy for SCID-X1
Vasandan, A. B., Abdelsamed, H. A., Boi, S. K., Ward, G., Alli, S., Mi, T., Lan, X., Zhang, X., Cowan, M. J., Puck, J. M., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.002 · Cited by 4
Self-citationAnti-CD3 mAb treatment reshapes infiltrating T and β cells in the islets in autoimmune diabetes
Wu, Y., Spurrell, M., Lledó-Delgado, A., Deng, S., Wang, D., Liu, Y., Barkestani, M. N., Perdigoto, A. L., & Herold, K. (2026) · JCI Insight · doi:10.1172/jci.insight.192755 · Cited by 5
Zhang, Y., Lu, Y., Gao, Y., Liang, X., Zhang, R., Wang, X., Zou, X., & Yang, W. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109890 · Cited by 3
Abdullatypov, A. V., Glushkova, O. V., Petriaikina, E. S., Bogdanov, V. P., Tabakov, D., Akimov, V. E., Yudin, V. S., Keskinov, A. A., Yudin, S. M., Volchkov, P., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1663728 · Cited by 3
Developing a comprehensive database and search tool for single-cell ATAC-seq data
Gibson-Khademi, A., Wang, J., Christensen, E., & Shooshtari, P. (2026) · Scientific Reports · doi:10.1038/s41598-025-09962-4 · Cited by 3
Barman, S., Räuber, S. J., Eisenhut, K., Esser, D., VanDuijn, M. M., Scharf, M., Herrera-Rivero, M., Disse, P., Preuth, L.-M., Gulyaeva, V., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2514753123 · Cited by 4
Yasumizu, Y., Hagiwara, M., Umezu, Y., Fuji, H., Iwaisako, K., Asagiri, M., Üemoto, S., Nakamura, Y., Thul, S., Ueyama, A., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae022 · Cited by 3
Steenbuck, N., Damond, N., Engler, S., Kusmartseva, I., Posgai, A. L., Drotar, D. M., Williams, M. D., de Souza, N., Brusko, T. M., Brusko, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.05.641526 · Cited by 3
How do autoimmune CD4+ T cells handle exhaustion?
Fabri, A., & Walker, L. S. K. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.11.004 · Cited by 2
Codazzi, V., Salvatore, V., Ragogna, F., Marzinotto, I., Anselmo, A., Baldoni, N., Pastore, M. R., Martinenghi, S., Stabilini, A., Bosi, E., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02497-x · Cited by 3
The Role of Epigenetics in Autoimmune Disorders
Klein, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00004-9 · Cited by 2
Mueller, A. L., Lamcaj, S., Garforth, S., Hiner, C. R., Woodley, D., Paraiso, K. D., Tian, M., Low, S., Youngblood, B., Almo, S. C., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00188-25 · Cited by 1
Self-citationZhao, Y., Samir, J., Keoshkerian, E., Li, H., An, H., Bull, R. A., Luciani, F., & Lloyd, A. R. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf299 · Cited by 1
Epigenetic Modifications and Their Role in Type 1 Diabetes Development: A Review
de Azevedo, J. C. V., Fernandes, F. L., Rodrigues, T. D., de Medeiros, I. A. C. M., Andrade, V. S., de Araújo, J. M. G., Bezerra, F. L., Bezerra, C. M., Fernandes, T. A. A. D. M., & Fernandes, J. V. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998399336251122042738 · Cited by 1
CD8+ T cells in atherosclerosis and coronary artery disease
Tandon, I., yosri, M., Soliman, H., Khalifa, A. M., Ley, K. F., & Abdelsamed, H. A. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01295-7 · Cited by 1
Self-citationLEF1 and niche factors determine T cell stemness across chronic diseases
Miakicheva, S., Hawley, K. M., Zumbo, P., Gearty, S. V., Grassmann, S. A., Naizir, B., Chiu, E., Carson, S., Kissner, M., Owyong, M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.06.022 · Cited by 1
Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes
Peters, L. D., Seay, H. R., Smith, J. A., Posgai, A. L., Berkowitz, R. L., Wasserfall, C. H., Atkinson, P. M. A., Bacher, R. L., Brusko, M., & Brusko, T. M. (2026) · Journal of Clinical Investigation · doi:10.1172/jci196445 · Cited by 1
UTX coordinates TCF1 and STAT3 to control progenitor CD8+ T cell fate in autoimmune diabetes
Chen, H.-C., Bang, M. F., Wang, H., Shpargel, K. B., Kohn, L. A., Sailer, D., Zhang, S. C., McCarthy, E. C., Seyedsadr, M., Stevens, S., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci196325 · Cited by 1
IL-12 Signaling Promotes TET2-Mediated DNA Demethylation During CD8 T Cell Effector DifferentiationPreprint
Zebley, C. C., Abdelsamed, H. A., Ghoneim, H. E., Alli, S., Haydar, D., Harris, T. L., McGargill, M. A., Krenciute, G., & Youngblood, B. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3720007 · Cited by 1
Self-citation
Metadata
- Authors
- Abdelsamed, H. A., Zebley, C. C., Nguyen, H., Rutishauser, R. L., Fan, Y., Ghoneim, H. E., Crawford, J. C., Alfei, F., Alli, S., Ribeiro, S. P., Castellaw, A. H., McGargill, M. A., Jin, H., Boi, S. K., Speake, C., Serti, E., Turka, L. A., Busch, M. E., Stone, M., Deeks, S. G., Sekaly, R.-P., Zehn, D., James, E. A., Nepom, G. T., & Youngblood, B.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Benaroya Research Institute (US)
- University of California, San Francisco (US)
- Technical University of Munich (DE)
- Case Western Reserve University (US)
- Immune Tolerance Network (US)
- Harvard University (US)
- Vitalant Research Institute (US)
- Corresponding author
- Youngblood, Ben
- ORCID
- Abdelsamed, Hossam A.
- Zebley, Caitlin C.
- Nguyen, Hai
- Rutishauser, Rachel L.
- Fan, Yiping
- Ghoneim, Hazem E.
- Crawford, Jeremy Chase
- Alli, Shanta
- Ribeiro, Susan Pereira
- Castellaw, Ashley H.
- McGargill, Maureen A.
- Jin, Hongjian
- Boi, Shannon K.
- Speake, Cate
- Serti, Elisavet
- Turka, Laurence A.
- Stone, Mars
- Deeks, Steven G.
- Zehn, Dietmar
- James, Eddie A.
- Nepom, Gerald T.
- Youngblood, Ben
- Venue
- Nature Immunology
- Published
- 2020-03-30
- Volume
- 21
- Issue
- 5
- Pages
- 578-587
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7183435
- OpenAlex
- W3013298623
- Cited by
- 121
- References
- 46
- Citations by year
- 2026: 14 · 2025: 23 · 2024: 20 · 2023: 14 · 2022: 20 · 2021: 23 · 2020: 6
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | National Institutes of Health (1R01AI114442, UM1AI109565)
- American Lebanese Syrian Associated Charities
- Assisi Foundation of Memphis
- U.S. Department of Health & Human Services | NIH | Division of Loan Repayment
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- type 1 diabetes, autoreactive T cells, DNA methylation, T cell differentiation, chromatin accessibility, T cell plasticity, T cell longevity, pancreatic beta cells
- MeSH terms
- Cell Plasticity, Adolescent, Adult, Animals, Autoantigens, Cells, Cultured, Diabetes Mellitus, Type 1, Female, Flow Cytometry, Humans, Immunologic Memory, Male, CD8-Positive T-Lymphocytes, DNA Methylation, Pluripotent Stem Cells, Epigenesis, Genetic, Insulin-Secreting Cells, Mice, Young Adult, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
